Tessa Buckle
About
In The Last Decade
Tessa Buckle
116 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 142
- Oncology 1.4k
- Molecular Biology 1.0k
- Pulmonary and Respiratory Medicine 1000
- Biomedical Engineering 851
- Radiology, Nuclear Medicine and Imaging 745
Countries citing papers authored by Tessa Buckle
This map shows the geographic impact of Tessa Buckle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tessa Buckle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tessa Buckle more than expected).
Fields of papers citing papers by Tessa Buckle
This network shows the impact of papers produced by Tessa Buckle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tessa Buckle. The network helps show where Tessa Buckle may publish in the future.
Co-authorship network of co-authors of Tessa Buckle
This figure shows the co-authorship network connecting the top 25 collaborators of Tessa Buckle. A scholar is included among the top collaborators of Tessa Buckle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tessa Buckle. Tessa Buckle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 7 | |
| 10 | 9 | |
| 11 | 62 | |
| 12 | 17 | |
| 13 | 3 | |
| 14 | 12 | |
| 15 | 10 | |
| 16 | Non-invasive longitudinal imaging of tumor progression using an 111Indium labeled CXCR4 peptide antagonist | 7 |
| 17 | 40 | |
| 18 | 161 | |
| 19 | 208 | |
| 20 | The impact of the ABC transporters P-gp and BCRP on the oral bioavailability and brain penetration of erlotinib using drug transporter knockout mouse models. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.